1-226883729-G-A
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_000447.3(PSEN2):c.166G>A(p.Gly56Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000124 in 1,614,128 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000447.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PSEN2 | NM_000447.3 | c.166G>A | p.Gly56Ser | missense_variant | 5/13 | ENST00000366783.8 | NP_000438.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PSEN2 | ENST00000366783.8 | c.166G>A | p.Gly56Ser | missense_variant | 5/13 | 5 | NM_000447.3 | ENSP00000355747.3 | ||
ENSG00000288674 | ENST00000366779.6 | n.166G>A | non_coding_transcript_exon_variant | 5/32 | 2 | ENSP00000355741.2 |
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 30AN: 152212Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000187 AC: 47AN: 250808Hom.: 0 AF XY: 0.000170 AC XY: 23AN XY: 135682
GnomAD4 exome AF: 0.000116 AC: 170AN: 1461798Hom.: 0 Cov.: 42 AF XY: 0.000129 AC XY: 94AN XY: 727200
GnomAD4 genome AF: 0.000197 AC: 30AN: 152330Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74482
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | research | Biesecker Lab/Clinical Genomics Section, National Institutes of Health | Jun 24, 2013 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jun 29, 2018 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Nov 11, 2022 | Variant summary: PSEN2 c.166G>A (p.Gly56Ser) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00019 in 282204 control chromosomes (gnomAD). c.166G>A has been reported in the literature in individuals affected with Parkinson Disease (Ibanez_2018) and Alzheimer Disease (Shim_2022). These reports do not provide unequivocal conclusions about association of the variant with Alzheimer Disease 4. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Three ClinVar submitters have assessed the variants since 2014: all classified the variant as likely benign. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
PSEN2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 24, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Alzheimer disease 4 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 05, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at